Health Care & Life Sciences » Pharmaceuticals | Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp. | Ownership

Companies that own Tonix Pharmaceuticals Holding Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Baker Bros. Advisors LP
699,500
7.35%
0
0.01%
06/30/2018
Rosalind Advisors, Inc.
553,908
5.82%
0
8.63%
12/31/2017
The Vanguard Group, Inc.
222,253
2.34%
23,716
0%
06/30/2018
Renaissance Technologies LLC
179,300
1.89%
71,300
0%
06/30/2018
Dimensional Fund Advisors LP
54,850
0.57%
6,332
0%
06/30/2018
Susquehanna Financial Group LLLP
49,451
0.52%
49,451
0%
06/30/2018
Geode Capital Management LLC
38,714
0.41%
38,714
0%
06/30/2018
Perinvest (UK) Ltd.
38,000
0.4%
38,000
0.24%
06/30/2017
JPMorgan Securities LLC (Investment Management)
29,438
0.31%
29,338
0%
06/30/2018
DRW Securities LLC
20,000
0.21%
0
0%
06/30/2018

About Tonix Pharmaceuticals Holding

View Profile
Address
509 Madison Avenue
New York New York 10022
United States
Employees -
Website http://www.tonixpharma.com
Updated 07/08/2019
Tonix Pharmaceuticals Holding Corp. operates as a clinical-stage pharmaceutical company, which engages in the development of pharmaceutical products for public health challenges. It focuses on delivering an efficacious, and safe long-term treatment for posttraumatic stress disorder. It offers TNX-102 SL, TNX-601, TNX-801, TNX-301, and TNX-701.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.